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SEAWATER-BASED BIOCATALYTIC STRATEGIES USING MARINE MICROORGANISMS
Bioprospecting of enzymes from marine bacteria and fungi from untapped deep-sea extreme habitats is the aim of this work, with reference to
ketoreductases, esterases, fructofuranosidases, and transaminases. Free enzymes or whole cells were used for biotransformations in fresh- or seawater.
The large consumption of freshwater in bioprocesses (fermentations and
biotransformations) is a matter of concern about the sustainability of many
bioprocesses. The use of seawater for carrying out bioprocesses seems a sustainable
alternative. Halotolerant marine microorganisms (and more generally halophilic
and/or halotolerant microorganisms) could be a plentiful source of enzymes for
accomplishing biocatalysis in seawater.
SWEET-AND-SALTY BIOCATALYSIS: FRUCTOOLIGOSACCHARIDES (FOS) PRODUCTION USING 
MARINE FUNGI IN SEAWATER 
Marine yeasts and moulds were screened for fructooligosaccharides (FOS)
production from sucrose (fructofuranosidases activity).
A halotolerant strain of Cladosporium cladosporioides (grown and used in seawater)
resulted an efficient producer of FOS from sucrose (600 g/L).2
.
The activity of the lyophilised mycelium showed to be stable for at least 30 cycles and
was used as immobilized system for a continuous process in flow reactors.3
STEREOSELECTIVE REDUCTIONS OF KETONES WITH MARINE YEASTS
Marine yeasts from deep-subseafloor sediments (isolated by University of Brest)
were grown and used in seawater for the stereoselective reduction of different
ketones.
Strains of Meyerozyma guilliermondii and Rhodotorula mucilaginosa were able to
enantioselectively reduce various aromatic ketones with high yields and moderate-
to-high enantioselectivity, with no major differences between biocatalysis carried out
in seawater or freshwater. Finally, the selected marine yeasts were used for the
reduction in seawater of key-intermediates for the synthesis of molecules of
pharmaceutical interest (desogestrel, norgestrel, gestodene, pramipexole).4
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Time-course of FOS production with lyophilized mycelium of C. cladosporioides. Reaction 
conditions: 600 g/L sucrose, 40 g/L lyophilized mycelium, seawater (pH 7.5), 50 °C
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Halotolerant bacterial strains have been screened with colorimetric
screening from a wide collection of isolates obtained from the seawater-
brine interface of different deep hypersaline anoxic basins (DHABs) of the
Eastern Mediterranean Sea, namely, Urania, Bannock, Discovery and
Atalante basins.
KETOREDUCTASES (KRED) AND ESTERASES (EST)
33 Strains were selected and used for the resolution of racemic propyl ester of anti-2-
oxotricyclo[2.2.1.0]heptan-7-carboxylic acid, a key intermediate for the synthesis of D-
cloprostenol.
Virgibacillus pantotheticus 21D showed high halotolerance, enantioselective KRED activity
in the presence of glucose, and Est activity was prevalent in the absence of glucose.1
TRANSAMINASES (TAM)
A screening was also carried out for finding transaminase (w-TAM) activities.
V. pantotheticus 21D showed high activity. Since its potential (different enantioselective
activities, significant halotolerance), the genome of Virgibacillus pantotheticus 21D was
sequenced.
Three genes (KRED1, EST1, TAM1) were identified by homology sequence and produced as
recombinant proteins in E. coli and are currently used for evaluating their potential as
enantioselective biocatalysts for the synthesis of molecules of pharmaceutical interest.
KRED1-Vpan:
EST1-Vpan:
Activity on racemic propyl ester 1 of whole cells of marine bacteria. a Biotransformation in the 
presence of glucose (5%); b Biotransformation in the absence of glucose. 
	
	 Growth	optimum	 3	 2	 	
Strain	 (NaCl	%)	 (%)	 ee	(%)	 (%)	 ee	(%)	 Time	(h)	
Bacillus	horneckiae	15Aa	 0-3	 <	5	 n.	d.	 58	 100	 3	
Halomonas	aquamarina	9Ba	 3	 57	 100	 <	5	 n.d.	 5	
Virgibacillus	pantotheticus	21D
a	
6-9	 <	5	 n.	d.	 58	 100	 6	
Virgibacillus	pantotheticus	21D
b	
6-9	 46	 88	 7	 n.d.	 6	
